Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,767 | 272 | 96.5% |
| Education | $136.27 | 6 | 3.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $661.79 | 43 | $0 (2018) |
| PFIZER INC. | $533.69 | 43 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $370.17 | 33 | $0 (2018) |
| Novo Nordisk Inc | $356.54 | 28 | $0 (2018) |
| SANOFI-AVENTIS U.S. LLC | $303.40 | 24 | $0 (2018) |
| Amgen Inc. | $242.57 | 14 | $0 (2024) |
| Lilly USA, LLC | $222.99 | 17 | $0 (2018) |
| Astellas Pharma US Inc | $218.82 | 9 | $0 (2018) |
| Kowa Pharmaceuticals America, Inc. | $198.48 | 8 | $0 (2018) |
| GlaxoSmithKline, LLC. | $162.43 | 6 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $41.24 | 2 | MEDICOMP INC ($25.39) |
| 2022 | $83.66 | 1 | GlaxoSmithKline, LLC. ($83.66) |
| 2019 | $15.03 | 1 | PFIZER INC. ($15.03) |
| 2018 | $1,618 | 112 | AstraZeneca Pharmaceuticals LP ($378.18) |
| 2017 | $2,146 | 162 | PFIZER INC. ($301.83) |
All Payment Transactions
278 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/09/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.85 | General |
| Category: Inflammation | ||||||
| 01/09/2024 | MEDICOMP INC | TELEPATCH CARDIAC MONITOR (Device) | Food and Beverage | In-kind items and services | $25.39 | General |
| Category: CARDIOLOGY | ||||||
| 02/09/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $83.66 | General |
| Category: RESPIRATORY | ||||||
| 07/10/2019 | PFIZER INC. | CHANTIX (Drug) | Education | In-kind items and services | $15.03 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 12/17/2018 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $12.00 | General |
| Category: Hypertriglyceridemia | ||||||
| 12/12/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA, INVOKAMET | Food and Beverage | In-kind items and services | $12.88 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/11/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.96 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/05/2018 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $16.26 | General |
| Category: Respiratory | ||||||
| 11/30/2018 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $12.65 | General |
| Category: Neuroscience | ||||||
| 11/28/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/27/2018 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: UROLOGY | ||||||
| 11/19/2018 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Vascepa | Food and Beverage | Cash or cash equivalent | $10.78 | General |
| Category: Cardiovascular | ||||||
| 11/15/2018 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $11.84 | General |
| Category: Diabetes | ||||||
| 11/14/2018 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: Respiratory | ||||||
| 11/09/2018 | Amgen Inc. | Prolia (Biological) | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: Endocrinology | ||||||
| 11/05/2018 | Promius Pharma LLC | Zembrace (Drug) | Food and Beverage | In-kind items and services | $12.27 | General |
| Category: Neurology | ||||||
| 11/02/2018 | PFIZER INC. | LYRICA (Drug) | Food and Beverage | In-kind items and services | $15.49 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 11/01/2018 | PFIZER INC. | LYRICA (Drug) | Food and Beverage | In-kind items and services | $0.38 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 10/31/2018 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $11.12 | General |
| Category: Neuroscience | ||||||
| 10/30/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/24/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.79 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/22/2018 | Lilly USA, LLC | TRADJENTA (Drug), TRULICITY, JARDIANCE | Food and Beverage | In-kind items and services | $12.36 | General |
| Category: Diabetes | ||||||
| 10/17/2018 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: Respiratory | ||||||
| 10/09/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.32 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/08/2018 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Vascepa | Food and Beverage | Cash or cash equivalent | $9.47 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,047 | 1,486 | $336,273 | $111,729 |
| 2022 | 12 | 1,023 | 1,508 | $274,849 | $109,386 |
| 2021 | 13 | 1,098 | 1,562 | $277,796 | $112,740 |
| 2020 | 16 | 1,083 | 1,464 | $263,480 | $92,049 |
All Medicare Procedures & Services
56 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 202 | 397 | $115,527 | $32,529 | 28.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 210 | 210 | $51,450 | $25,647 | 49.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 244 | 452 | $84,734 | $24,924 | 29.4% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 88 | 89 | $16,016 | $6,736 | 42.1% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 21 | 22 | $16,324 | $6,195 | 37.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 29 | 36 | $15,300 | $4,317 | 28.2% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 16 | 22 | $8,514 | $3,287 | 38.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 90 | 91 | $5,096 | $2,654 | 52.1% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 17 | 17 | $6,086 | $2,650 | 43.5% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 11 | 11 | $7,942 | $1,244 | 15.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 21 | 22 | $1,298 | $641.74 | 49.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 42 | 44 | $4,092 | $388.36 | 9.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 27 | 44 | $3,056 | $382.33 | 12.5% |
| G0403 | Electrocardiogram, routine ecg with 12 leads; performed as a screening for the initial preventive physical examination with interpretation and report | Office | 2023 | 12 | 12 | $600.00 | $75.74 | 12.6% |
| 81002 | Urinalysis, manual test | Office | 2023 | 17 | 17 | $238.00 | $57.97 | 24.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 236 | 462 | $109,908 | $38,964 | 35.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 209 | 209 | $51,205 | $26,631 | 52.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 258 | 464 | $74,559 | $25,983 | 34.8% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 87 | 87 | $8,805 | $6,112 | 69.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 33 | 38 | $11,969 | $5,081 | 42.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 94 | 95 | $5,320 | $2,664 | 50.1% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 15 | 16 | $5,534 | $2,515 | 45.5% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 11 | 12 | $2,100 | $609.32 | 29.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 21 | 41 | $2,323 | $401.89 | 17.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 37 | 40 | $2,628 | $357.69 | 13.6% |
About Dr. Scott Mccune, MD
Dr. Scott Mccune, MD is a Internal Medicine healthcare provider based in Huntersville, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1407876675.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Scott Mccune, MD has received a total of $3,903 in payments from pharmaceutical and medical device companies, with $41.24 received in 2024. These payments were reported across 278 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($3,767).
As a Medicare-enrolled provider, Mccune has provided services to 4,251 Medicare beneficiaries, totaling 6,020 services with total Medicare billing of $425,904. Data is available for 4 years (2020–2023), covering 56 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Huntersville, NC
- Active Since 07/20/2006
- Last Updated 02/03/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1407876675
Products in Payments
- FARXIGA (Drug) $403.34
- CHANTIX (Drug) $218.48
- Victoza (Drug) $218.15
- INVOKANA (Drug) $203.45
- Livalo (Drug) $198.48
- XARELTO (Drug) $166.72
- BEVESPI AEROSPHERE (Drug) $156.04
- ELIQUIS (Drug) $134.82
- TRULICITY (Drug) $131.89
- SOLIQUA (Drug) $118.18
- Repatha (Biological) $117.40
- LYRICA (Drug) $111.22
- TOUJEO (Drug) $108.24
- SYMBICORT (Drug) $102.41
- Saxenda (Drug) $88.90
- Myrbetriq (Drug) $85.99
- Prolia (Biological) $85.55
- TRELEGY ELLIPTA (Drug) $83.66
- TRADJENTA (Drug) $78.41
- PRALUENT (Drug) $76.98
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Huntersville
Alexis Smith, D.o, D.O
Internal Medicine — Payments: $492,236
Glen Kowalchuk, Md, MD
Internal Medicine — Payments: $93,721
William Hoover, Md, MD
Internal Medicine — Payments: $33,144
Dr. William Mitchell, Md, MD
Internal Medicine — Payments: $31,201
Poras Patel
Internal Medicine — Payments: $20,257
Jennifer Dallas, Md, MD
Internal Medicine — Payments: $17,309